Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune-Antibody-Mediated Hemolytic Anemia

John “philip” Philip Johnson, Dylan B Ness, Lionel D Lewis, Brittany E Condict, Christopher H. Lowrey, Matthew R Sullivan

Blood (2024) 144 (Supplement 1): 3830.

https://doi.org/10.1182/blood-2024-194379

Published: 2024

Journal Articles

Utility of Targeted Neurocognitive Testing in Detecting Early Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CAR T-Cell Therapy

Arvind Suresh, Maeen N. Arslan, Heather A. Wishart, Amy M. Chan, Bryce S. Jacobson, Grant Moncrief, Christopher H. Lowrey, Christi Ann Hayes, Susan C. Brighton, Dorothy R. McKenna, Lisa J. Wesinger, Judi A. Gentes, Kate L. Caldon, Zbigniew M. Szczepiorkowski, Kenneth R. Meehan, John M. Hill, Jr.

Blood (2022) 140 (Supplement 1): 4686–4687.

https://doi.org/10.1182/blood-2022-168112

Published: 2022

Journal Articles

Patient Reported Outcomes for Patients Receiving a Hematopoietic Stem Cell Transplant: A Longitudinal Assessment with a Dashboard Display

Christi Ann Hayes, Kenneth R. Meehan, Elizabeth A O'Donnell, Aricca Van Citters, Kate L. Caldon, Charlotte M Coughenour, Dorothy R. McKenna, Carla Tarzia, Wenyan Zhao, Kimberley R Holt, Christopher H. Lowrey, John M. Hill, Jr., Tiffany D'Cruze, Megan M Holthoff, Tor Tosteson, Anna Tosteson

Blood (2022) 140 (Supplement 1): 8113–8114.

https://doi.org/10.1182/blood-2022-163437

Published: 2022

Journal Articles

Randomized Phase II Study to Assess the Role of Nivolumab As Single Agent to Eliminate Minimal Residual Disease and Maintain Remission in Acute Myelogenous Leukemia (AML) Patients after Chemotherapy (NCI9706 protocol; REMAIN Trial)

Blood (2022) 140 (Supplement 1): 1716–1719.

https://doi.org/10.1182/blood-2022-157326

Published: 2022

Journal Articles

Down the repressors! Up the fetal hemoglobin!

Christopher H. Lowrey

Blood (2016) 127 (11): 1384–1385.

https://doi.org/10.1182/blood-2016-01-689018

Published: 2016

Journal Articles

Induction of fetal hemoglobin through enhanced translation efficiency of γ-globin mRNA

Cynthia K. Hahn, Christopher H. Lowrey

Blood (2014) 124 (17): 2730–2734.

https://doi.org/10.1182/blood-2014-03-564302

Published: 2014

Includes: Supplemental data

Journal Articles

Microrna Expression In Patients With Myelodysplastic Syndromes Treated With Demethylating Agents

Meir Preis, MD, PhD, Gregory J Tsongalis, PhD, Christopher H. Lowrey, MD, Deborah L. Ornstein, MD

Blood (2013) 122 (21): 3758.

https://doi.org/10.1182/blood.V122.21.3758.3758

Published: 2013

Journal Articles

Uncovering a Covert Enemy: Systemic AL Amyloidosis Associated With Intravascular Diffuse Large B-Cell Lymphoma

Joseph J. Shatzel, MD, Rebecca Wang, BS, Regina C. Lee, MD, Saurabh Malhotra, MD, Kabir Mody, MD, Deborah L. Ornstein, MD, Christopher H. Lowrey, MD

Blood (2013) 122 (21): 5066.

https://doi.org/10.1182/blood.V122.21.5066.5066

Published: 2013

Journal Articles

Eukaryotic initiation factor 2α phosphorylation mediates fetal hemoglobin induction through a post-transcriptional mechanism

Cynthia K. Hahn, Christopher H. Lowrey

Blood (2013) 122 (4): 477–485.

https://doi.org/10.1182/blood-2013-03-491043

Published: 2013

Includes: Supplemental data

Journal Articles

Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells

Elizabeth R. Macari, Emily K. Schaeffer, Rachel J. West, Christopher H. Lowrey

Blood (2013) 121 (5): 830–839.

https://doi.org/10.1182/blood-2012-07-443986

Published: 2013

Journal Articles

Salubrinal Increases Human Fetal Hemoglobin Production Through a Post-Transcriptional Mechanism

Cynthia K Hahn, BA, Christopher H. Lowrey, MD

Blood (2012) 120 (21): 250.

https://doi.org/10.1182/blood.V120.21.250.250

Published: 2012

Journal Articles

Simvastatin and tBHQ Act Synergistically to Increase γ-Globin Gene Expression Through the Transcription Factors KLF2 and NRF2

Elizabeth R Macari, BS, Christopher H. Lowrey, MD

Blood (2011) 118 (21): 2149.

https://doi.org/10.1182/blood.V118.21.2149.2149

Published: 2011

Journal Articles

p38 MAPK Signalling Is Not Sufficient to Induce γ-Globin Gene Expression

Emily K Schaeffer, BSc, Rachel J West, PhD, Cynthia K Hahn, BA, Christopher H. Lowrey, MD

Blood (2011) 118 (21): 1083.

https://doi.org/10.1182/blood.V118.21.1083.1083

Published: 2011

Journal Articles

Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway

Elizabeth R. Macari, Christopher H. Lowrey

Blood (2011) 117 (22): 5987–5997.

https://doi.org/10.1182/blood-2010-10-314096

Published: 2011

Journal Articles

Exploiting the NRF2/Antioxidant Response Element Signaling Pathway to Induce γ-Globin Gene Expression and HbF Production

Elizabeth R. Macari, BS, Rachel J. West, PhD, Christopher H. Lowrey, MD

Blood (2010) 116 (21): 2074.

https://doi.org/10.1182/blood.V116.21.2074.2074

Published: 2010

Journal Articles

Dual-Specificity Phosphatases (DUSPs) Are Potential Targets for Pharmacologic Induction of Fetal Hemoglobin

Cynthia K Hahn, BA, Rachel J West, PhD, Elizabeth R Macari, BS, Emily K Schaeffer, BSc, Christopher H. Lowrey, MD

Blood (2010) 116 (21): 2075.

https://doi.org/10.1182/blood.V116.21.2075.2075

Published: 2010

Journal Articles

X-Ray and UV Irradiation and Heat Shock Induce γ-Globin Gene Expression in Erythroid Cells Via P38 MAPK Signaling.

Rachel West, PhD, Rodwell Mabaera, PhD, Sarah Conine, Elizabeth Macari, BS, William J. Lowrey, Anais L Carniciu, Christopher H. Lowrey, MD

Blood (2009) 114 (22): 459.

https://doi.org/10.1182/blood.V114.22.459.459

Published: 2009

Journal Articles

Induction of γ-Globin Gene Expression Via the Nrf2/Antioxidant Response Element Signaling Pathway.

Elizabeth Macari, BS, Rachel West, PhD, William J. Lowrey, Rodwell Mabaera, PhD, Christopher H. Lowrey, MD

Blood (2009) 114 (22): 975.

https://doi.org/10.1182/blood.V114.22.975.975

Published: 2009

Journal Articles

5-Azacytidine Induces Human Fetal Hemoglobin Production through Activation of the p38 MAPK and Integrated Stress Response Signaling Pathways

Rodwell Mabaera, Christopher H. Lowrey, MD

Blood (2008) 112 (11): 489.

https://doi.org/10.1182/blood.V112.11.489.489

Published: 2008

Journal Articles

Response: 5-azacytidine induction of human fetal hemoglobin

Rodwell Mabaera, Christopher H. Lowrey

Blood (2008) 111 (4): 2486.

https://doi.org/10.1182/blood-2007-11-125070

Published: 2008

NARROW

The Safety of Repurposing Daratumumab for Relapsed or Refractory Autoimmune-Antibody-Mediated Hemolytic Anemia

Utility of Targeted Neurocognitive Testing in Detecting Early Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS) after CAR T-Cell Therapy

Patient Reported Outcomes for Patients Receiving a Hematopoietic Stem Cell Transplant: A Longitudinal Assessment with a Dashboard Display

Randomized Phase II Study to Assess the Role of Nivolumab As Single Agent to Eliminate Minimal Residual Disease and Maintain Remission in Acute Myelogenous Leukemia (AML) Patients after Chemotherapy (NCI9706 protocol; REMAIN Trial)

Down the repressors! Up the fetal hemoglobin!

Induction of fetal hemoglobin through enhanced translation efficiency of γ-globin mRNA

Microrna Expression In Patients With Myelodysplastic Syndromes Treated With Demethylating Agents

Uncovering a Covert Enemy: Systemic AL Amyloidosis Associated With Intravascular Diffuse Large B-Cell Lymphoma

Eukaryotic initiation factor 2α phosphorylation mediates fetal hemoglobin induction through a post-transcriptional mechanism

Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells

Salubrinal Increases Human Fetal Hemoglobin Production Through a Post-Transcriptional Mechanism

Simvastatin and tBHQ Act Synergistically to Increase γ-Globin Gene Expression Through the Transcription Factors KLF2 and NRF2

p38 MAPK Signalling Is Not Sufficient to Induce γ-Globin Gene Expression

Induction of human fetal hemoglobin via the NRF2 antioxidant response signaling pathway

Exploiting the NRF2/Antioxidant Response Element Signaling Pathway to Induce γ-Globin Gene Expression and HbF Production

Dual-Specificity Phosphatases (DUSPs) Are Potential Targets for Pharmacologic Induction of Fetal Hemoglobin

X-Ray and UV Irradiation and Heat Shock Induce γ-Globin Gene Expression in Erythroid Cells Via P38 MAPK Signaling.

Induction of γ-Globin Gene Expression Via the Nrf2/Antioxidant Response Element Signaling Pathway.

5-Azacytidine Induces Human Fetal Hemoglobin Production through Activation of the p38 MAPK and Integrated Stress Response Signaling Pathways

Response: 5-azacytidine induction of human fetal hemoglobin

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only